FIELD: chemistry.
SUBSTANCE: invention relates to a heterocyclic compound of formula 
,
where A represents NRB, where RB represents hydrogen; X1 and X2 represent CR2 and X3, X4, X5 and X6 represent CR3 or CR4, or X1 and X2 represent CR2, X3 represent N, and X4, X5 and X6 represent CR3; Y1, Y2, Y3 and Y4 represent CR4 or CR5 or Y2 represents N, and Y1, Y3 and Y4 represent CR5; provided that no more than one of Y1, Y2, Y3 and Y4 represents CR4; and provided that one of Y1, Y2, Y3 and Y4 represents CR4 or C-CF3, if none of X3, X4, X5 and X6 represents CR4; R1 represents hydrogen; each R2 represents hydrogen; each R3 is independently selected from the group consisting of hydrogen, CN, halogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy and C1-C6-haloalkoxy; R4 represents a C-linked saturated or partially unsaturated monocyclic 5- or 6-member heterocyclic ring containing one heteroatom selected from O and N, as ring members, wherein the heterocyclic ring optionally has one N-linked substituent R8; R5 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl and C3-C7-cycloalkyl; and R8 is selected independently on the case from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl and C1-C6-alkoxycarbonyl. The invention also relates to pharmaceutical compositions based on a formula (I) compound, formula (I) compound application, a method of treatment of diseases susceptible to treatment by a compound that modulates the activity of 3β glycogen synthase kinase.
EFFECT: new heterocyclic compounds useful for treatment of neurodegenerative disorders or inflammatory diseases are obtained.
25 cl, 2 tbl, 70 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRROLIDINE AND PIPERIDINE COMPOUNDS | 2020 |
|
RU2803455C1 |
| USING EP4 RECEPTOR ANTAGONISTS IN TREATING IL-23-MEDIATED DISEASES | 2011 |
|
RU2571816C2 |
| NEW QUINOLINE DERIVATIVES | 2019 |
|
RU2792933C2 |
| USE OF EP4 RECEPTOR ANTAGONIST IN TREATMENT OF CARTILAGE DISEASE | 2014 |
|
RU2663620C2 |
| FUNGICIDAL DERIVATIVES OF N'-[2-METHYL-6 [2-ALKOXYETHOXY]-3-PYRIDYL]-N-ALKYLFORMAMIDINE FOR USE IN AGRICULTURE | 2015 |
|
RU2701370C2 |
| AVERMECTIN B1 AND AVERMEKTINE B1 MONOSACCHARIDE DERIVATIVES WITH ALKOXYMETHYL SUBSTITUTE IN THE POSITION 4"- OR 4'- | 2003 |
|
RU2330857C2 |
| DIHYDROBENZOPYRANE DERIVATIVES WITH VASOCONSTRICTIVE EFFECT, INTERMEDIATE COMPOUNDS, PREPARATION METHODS, PHARMACEUTICAL COMPOSITION, METHOD OF PREPARING THEREOF | 1994 |
|
RU2129556C1 |
| QUINOLINE COMPOUNDS, METHODS FOR PRODUCTION THEREOF AND USE THEREOF AS MEDICINAL AGENT WHICH INHIBITS URATE TRANSPORTER | 2016 |
|
RU2715229C2 |
| NOVEL HETEROCYCLIDENE ACETAMIDE DERIVATIVE | 2006 |
|
RU2451014C2 |
| CONDENSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2700004C1 |
